Regeneron Pharmaceuticals, Inc. (REGN) Tops Q2 EPS by 81c

August 6, 2013 6:51 AM

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q2 EPS of $1.73 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found